Selegiline - Compound Summary (CID 26758)
Also known as: Selegiline hydrochloride, Zelapar, l-Deprenyl hydrochloride, Zydis selegiline, Jumex hydrochloride, Selegiline Hcl, Eldepryl hydrochloride
Molecular Formula: C13H18ClN   Molecular Weight: 223.74172   InChIKey: IYETZZCWLLUHIJ-UTONKHPSSA-N
A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.   From: MeSH
Show subcontent titlesTable of Contents
Identification
Related Records
show first sub-section only
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Exposure Standards and Regulations
Monitoring and Analysis Methods
Literature
Biological Test Results
Classification
Chemical and Physical Properties
_ _